|
 |
|
|
 |
Rajan Saggar, M.D.. |
 |
Cindy Coney, M.Ed. |
"Maximizing Life, Minimizing Stress" by Cindy Coney, M.Ed. and "Pulmonary Hypertension" by Rajan Saggar, M.D. |
|
|
Ever wish you could discuss with other individuals your questions or concerns regarding your Actelion PAH medications? Well, wait no more!
Shal Jacobovitz, President of Actelion Pharmaceuticals, announced this past Tuesday, July 1st, that Actelion will be launching a new patient support service entitled: Sure Steps Connect: A Web Program for Patients on Actelion PAH Medications. |
|
|
Thanks to its ongoing partnership with the Pulmonary Hypertension Association, The Scleroderma Foundation took part in the Association’s 8th International PHA Conference this past June in Houston, Texas. |
|
|
BOTHELL, WA – MediQuest Therapeutics Inc. today announced that it has been granted priority review status from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for MQX-503, a topical formulation designed to treat Raynaud’s Disease.
|
|
|
How does a caregiver know when he or she can no longer manage the daily caregiving routines and planning responsibilities? What signals alert the caregiver that he or she is in trouble of getting lost in caregiving? Can a caregiver who cherishes a loved one set limits on responsibilities without feeling guilty or morally bankrupt? These are questions at the heart of successful, long-term caregiving. |
|
|
The Wall Street Journal - In more than 32 years with McDonald's, I worked my way up from grill man to president and CEO by focusing on providing shareholder value while fulfilling a need. In that vein I'd like to recognize the 25th anniversary this year of a groundbreaking piece of legislation that has made it easier for drug companies to do exactly that. |
|
|
Researchers from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the National Institutes of Health (NIH), have identified a promising new target for autoimmune disease treatment — a cell-surface receptor called DR3. |
|
The Nationwide Series Returns to Daytona
With eighteen races completed, the NASCAR Nationwide Series starts the second half of its season with the Daytona 250 at the famed Daytona International Speedway. It is one of the two tracks the circuit that uses restrictor plates to slow the cars down due to the high banking, the other being Talladega Superspeedway. However, there are some differences in the racing at the two tracks, as Daytona is narrower and more handling-oriented than Talladega, which allows the huge packs to break up somewhat on long runs, which makes "the Big One" that plate tracks are famous for less frequent and usually on a start or restart, as opposed to Talladega, where such huge wrecks occurs in almost every race in almost any situation.
You can celebrate the Fourth of July and watch Bobby Hamilton Jr. and the Team Rensi Motorsport/Smithfield #25 Ford Fusion on Friday at 7:30 p.m., EST on ESPN2. Check your local listings for the time in your area.
In the meantime, check out the great photo (click for larger version) of The Scleroderma Foundation’s Mary Ann Berman along with Bobby Hamilton Jr. next to the #25 car (note Scleroderma logo on the car as well as on Mary Ann’s hat. Also note Mary Ann’s T-shirt which sports the Rensi and Smithfield logos. See the "Photo of the Week" for the huge Scleroderma logo on the back of the shirt.)
|
|
|
